The GSTP1 Ala114Val carriers were associated with an increased risk of glioma in the overall population (OR=1.163(1.002- 1.350); P=0.047) and in the Caucasian population (OR=1.215(1.001-1.476); P=0.049) (Figure 3). Here, GSTP1 is linked to glioma.